After RBC Capital and Piper Sandler gave Pliant Therapeutics (NASDAQ: PLRX) a Buy rating last month, the company received another Buy, this time from H.C. Wainwright. Analyst Ed Arce maintained a Buy rating on Pliant Therapeutics yesterday and set a price target of $45.00. The company’s shares closed last Monday at $23.00.
According to TipRanks.com, Arce is a 4-star analyst with an average return of 8.0% and a 39.5% success rate. Arce covers the Healthcare sector, focusing on stocks such as Entasis Therapeutics Holdings, Aurinia Pharmaceuticals, and Paratek Pharmaceuticals.
Pliant Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $40.20, implying a 151.1% upside from current levels. In a report released yesterday, Cantor Fitzgerald also maintained a Buy rating on the stock with a $36.00 price target.
Based on Pliant Therapeutics’ latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $1.25 million and GAAP net loss of $28.1 million. In comparison, last year the company earned revenue of $2.17 million and had a GAAP net loss of $22.86 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.
Read More on PLRX:
- Uniper SE (UNPRF) Gets a Buy Rating from J.P. Morgan
- Canaccord Genuity Keeps a Buy Rating on Resolute Mining Limited (RMGGF)
- ironSource Stock: Unjustified Sell-Off Presents a Solid Opportunity
- Costa Group Holdings Ltd. (CTTQF) Receives a Buy from Goldman Sachs
- Analysts Conflicted on These Consumer Goods Names: a2 Milk Company Ltd. (OtherACOPF) and Wesfarmers Limited (OtherWFAFF)